Company intelligence / Profile preview

Boyds

Philadelphia area, Pennsylvania, United Statesboydsgunstocks.com ↗

Ownership: Private
Development stage: Other

Overview

Boyds is a global drug development consultancy specializing in supporting pharmaceutical, biotech, medical device companies, and academic groups to translate scientific ideas into medicinal products. The company has particular expertise in advanced therapies such as cell and gene therapies, small molecules, biologics, orphan drugs, and medical devices. It provides services across program management, product development, regulatory affairs/strategy/operations, clinical operations/monitoring/writing/due diligence for international clients at all stages of the drug/device lifecycle.

Modalities: Cell therapyGene therapySmall moleculeBiologicOrphan drug
Industry: Consulting

Partnerships

BioPharma Connections partnership announced in February 2024 to expand US growth.

Beyond the preview

Go deeper on Boyds.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Boyds.

Explore the full profile